Ascend Advanced Therapies, a contract development and manufacturing organisation based in Maryland, US, has received good manufacturing practice (GMP) certification for quality control (QC) testing at its site in Munich, Germany. This will streamline testing and release of adeno-associated (AAV)-based gene therapy. The Munich facility is now permitted to perform advanced commercial assays for DNA […]
The post Ascend granted certification for quality control testing at Munich facility appeared first on Pharmafile.
